Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04244786 · ClinicalTrials.gov registry record · NA

Treating Self Injurious Behavior: A Novel Brain Stimulation Approach

A NA study of Depression and Bipolar Disorder, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT04244786: Completed NA study of Depression and Bipolar Disorder, sponsored by New York State Psychiatric Institute.

NCT04244786 is a NA study of Depression and Bipolar Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 13 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04244786, a NA study of Depression and Bipolar Disorder, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to explore the tolerability and effectiveness of transcranial direct current stimulation (tDCS) as a potential treatment for non-suicidal self-injury (NSSI). Individuals who engage in frequent NSSI will be randomized to 12 administrations of an active vs. inactive form of tDCS, paired with an Attention Training Technique task, over a two-week period. Functional MRI may be performed before and after this two week period. NSSI urges and behaviors will be monitored before, during, and after the period of tDCS administrations.

Primary Outcome

The Cyberball task is a task used during functional MRI scanning. During the task, individuals play a virtual ball-tossing game, playing catch with two computer avatars, and have a social exclusion experience when the avatars stop tossing the ball to them. The outcome measure is a subtraction of a measure of brain activity (fMRI BOLD signal) during portions of the task when the individual is included in the virtual ball-tossing game as compared to periods when the individual is excluded (i.e. fM

Conditions Studied

Depression Bipolar Disorder Self Injurious Behavior Self Harm Self-Injury Nonsuicidal Self Injury Self Injurious Behavior Without Suicidal Intent Self-inflicted Injury Non Suicidal Self Inflicted Injury Cutting

Interventions

  • OTHER No intervention
  • DEVICE Transcranial direct current stimulation

Study Locations (1)

New York

  • New York State Psychiatric Institute/Columbia University - New York

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2019-10-01
Est. Completion 2022-07-29
Phase NA
New York State Psychiatric Institute

364 total trials

What the finished NCT04244786 record still lists

NCT04244786 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (98% lower).

The record links to 10 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which No intervention is the first listed.

NCT04244786 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04244786 about?

NCT04244786 is a clinical study titled "Treating Self Injurious Behavior: A Novel Brain Stimulation Approach". The purpose of this study is to explore the tolerability and effectiveness of transcranial direct current stimulation (tDCS) as a potential treatment for non-suicidal self-injury (NSSI). Individuals who engage in frequent NSSI will be randomized to 12 administrations of an active vs. inactive form o...

What is the current status of trial NCT04244786?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2019-10-01. Estimated completion is 2022-07-29.

What conditions does trial NCT04244786 study?

This clinical trial studies the following conditions: Depression, Bipolar Disorder, Self Injurious Behavior, Self Harm, Self-Injury.

What interventions are being tested in trial NCT04244786?

The interventions under investigation include: No intervention (OTHER), Transcranial direct current stimulation (DEVICE).

Who is sponsoring clinical trial NCT04244786?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04244786 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04244786's enrollment target sits among peer trials

13 651st of 679 higher than 27 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Related registry views

Source: ClinicalTrials.gov NCT04244786, the US trial registry maintained by the National Library of Medicine. NCT04244786 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.